| Literature DB >> 35392240 |
Weijie Dong1, Bing Zhu2, Yan You3, Bing Wang2, Dan Fu4, Daoxin Wang2, He Li1, Changyi Li1.
Abstract
Primary pulmonary mucoepidermoid carcinoma (PMEC) is a very rare form of lung carcinoma. Due to the low incidence, little is known about its inherent genetic variation characteristics. The uniform treatment for PMEC has not been determined. In this case, we present a 45-year-old male with stage IA PMEC. The surgical specimens contained changes from low- to intermediate-to-high grade. We performed integrative analysis of whole-exome sequencing (WES-seq) and messenger ribonucleic acid sequencing (RNA-seq) to compare the molecular changes in the different lesions. Molecular testing exhibits the specimens harboring CRTC3-MAML2 fusion. The copy number gain of PDPK1 is only present in high-grade regional specimens. We also explored the level of immune infiltration by CIBERSORT. To our knowledge, this is the first report to describe a case of PMEC in the low- to intermediate-high-grade transition with multiomics analysis.Entities:
Keywords: CRTC1-MAML2 and CRTC3-MAML2 fusion; PDPK1; RNA-seq; WES-seq; primary pulmonary mucoepidermoid carcinoma
Year: 2022 PMID: 35392240 PMCID: PMC8980482 DOI: 10.3389/fonc.2022.820966
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244